{"Symbol": "ARQT", "AssetType": "Common Stock", "Name": "Arcutis Biotherapeutics\u00a0Inc", "Description": "Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.", "CIK": "1787306", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA, UNITED STATES, 91361", "OfficialSite": "https://www.arcutis.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "3167648000", "EBITDA": "-33189000", "PERatio": "None", "PEGRatio": "None", "BookValue": "1.314", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.34", "RevenuePerShareTTM": "2.515", "ProfitMargin": "-0.139", "OperatingMarginTTM": "0.0859", "ReturnOnAssetsTTM": "-0.0591", "ReturnOnEquityTTM": "-0.282", "RevenueTTM": "317929000", "GrossProfitTTM": "286017000", "DilutedEPSTTM": "-0.34", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "1.217", "AnalystTargetPrice": "31.75", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "5", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "60.24", "PriceToSalesRatioTTM": "9.96", "PriceToBookRatio": "20.03", "EVToRevenue": "9.72", "EVToEBITDA": "-2.04", "Beta": "1.683", "52WeekHigh": "31.77", "52WeekLow": "11.75", "50DayMovingAverage": "27.86", "200DayMovingAverage": "20.2", "SharesOutstanding": "122492000", "SharesFloat": "89433000", "PercentInsiders": "1.671", "PercentInstitutions": "105.116", "DividendDate": "None", "ExDividendDate": "None"}